Geneesmiddelenbeleid

This motion concerns the national pharmaceutical policy in the Netherlands. It aims to address the management, accessibility, and strategic oversight of medicinal products to ensure public health stability. This procedure affects the healthcare sector, pharmaceutical companies, and patients by potentially altering how medicines are procured, priced, or distributed.